Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zhao, Jinguo
STRATEGY, NCT05310968: Study on Tirofiban With Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction	Recruiting	4	970	RoW	Tirofiban hydrochloride sodium chloride injection, Tirofiban hydrochloride sodium chloride injection placebo, Aspirin	Beijing Tiantan Hospital, GrandPharma (China) Co., Ltd.	Branch Atheromatous Disease	06/24	09/24
SHINY, NCT06157502: Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke	Recruiting	3	1380	RoW	Shuxuening Injection, Placebo	Beijing Tiantan Hospital	Ischemic Stroke, Acute	06/25	12/26
TAPIS, NCT06316570: Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke	Recruiting	3	1380	RoW	Early Dual Antiplatelet Therapy, Ticagrelor and Aspirin, Placebo, Placebo of Ticagrelor and Aspirin	Beijing Tiantan Hospital	Ischemic Stroke, Acute	12/25	12/26
NCT03640884: Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study	Recruiting	N/A	30000	RoW	Xueshuantong-Injection, Chenzhong	Zhong Wang	Adverse Drug Event, Adverse Drug Reactions, Anaphylactic Reaction, Severe Adverse Reactions	12/21	06/22